Skip to main content
SpringerLink
Log in

Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

To examine whether serum urate level and other aspects of gouty arthritis are independently associated with Q-wave myocardial infarction (QWMI) in gouty population, we performed a cross-sectional study. A total of 22,572 gouty cases were enrolled. QWMI was defined as a positive finding by resting electrocardiographic criteria excluding the conditions producing pseudoinfarction. The variables of gout were tested univariately and multivariately, controlling for the covariates by logistic regression analysis. The above analysis was then repeated in subgroups of young-aged (<50 years), old-aged (≧50 years), male, and female patients. Increased serum urate level was significantly associated with QWMI in all subjects and male subgroup [odds ratio (OR), 1.120; 95% confidence interval (CI), 1.020–1.229; OR, 1.106; 95% CI, 1.001–1.223, respectively, for each mg/dl increment]. After controlling for serum urate level and the covariates, increased affected joint count was also independently associated with QWMI finding in all subjects, male and old-aged subgroups (OR, 1.098; 95% CI, 1.014–1.189; OR, 1.094; 95% CI, 1.005–1.192; OR, 1.095; 95% CI, 1.001–1.199, respectively). Tophi formation was independently associated with QWMI in young-aged subgroup (OR, 2.494; 95% CI, 1.159–5.366). None of the variables of gout including hyperuricemia was significantly associated with QWMI in female subgroup after controlling for covariates. This study first demonstrates that gout is associated with QWMI by both the severity of gouty arthritis and serum urate level, while the association of urate to QWMI could be different between age strata and genders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Chang HY, Pan WH, Yeh WT, Tsai KS (2001) Hyperuricaemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993–96). J Rheumatol 28(7):1640–1646

    PubMed  CAS  Google Scholar 

  2. Wortmann RL, Kelley WN (2001) Gout and hyperuricemia. In: Ruddy S, Harris ED Jr, Sledge CB (eds) Kelley’s textbook of rheumatology, 6th edn. Saunders, Philadelphia, PA, pp 1339–1376

    Google Scholar 

  3. Brand FN, McGee DL, Kannel WB et al (1985) Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 121(1):11–18

    PubMed  CAS  Google Scholar 

  4. Freedman DS, Williamson DF, Gunter EW et al (1995) Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I epidemiologic follow-up study. Am J Epidemiol 141:637–644

    PubMed  CAS  Google Scholar 

  5. Culleton BF, Larson MG, Kannel WB et al (1999) Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med 131:7–13

    PubMed  CAS  Google Scholar 

  6. Tweddale MG, Fodor JG (1979) Elevated serum uric acid: a cardiovascular risk factor. Nephron 23:3

    Google Scholar 

  7. Fessel WJ (1980) High uric acid as an indicator of cardiovascular disease, independence from obesity. Am J Med 68:401

    Article  PubMed  CAS  Google Scholar 

  8. Johnson MW, Mitch WE (1981) The risks of asymptomatic hyperuricemia and the use of uricosuric diuretics. Drugs 21:220

    PubMed  CAS  Google Scholar 

  9. Alderman MH, Cohen H, Madhavan S et al (1999) Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 34:144–150

    PubMed  CAS  Google Scholar 

  10. Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. JAMA 283:2404–2410

    Article  PubMed  CAS  Google Scholar 

  11. Verdecchia P, Schillaci G, Reboldi G et al (2000) Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the PIUMA study. Hypertension 36:1072–1078

    PubMed  CAS  Google Scholar 

  12. Wang J-G, Staessen JA, Fagard RH et al (2001) Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 37:1069–1074

    PubMed  CAS  Google Scholar 

  13. Wallace SL, Robinson H, Masi AT et al (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895–900

    PubMed  CAS  Google Scholar 

  14. Goldschlager N, Goldman MJ (1984) Electrocardiography: essentials of interpretation. Lange Medical Publications, California

    Google Scholar 

  15. Taussig AS (1983) Misleading ECGs: patterns of infarction. J Cardiovasc Med 1:561

    Google Scholar 

  16. Denke M, Wilson JD (1998) Assessment of nutritional status. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL (eds) Harrison’s principles of internal medicine, 14th edn. McGraw-Hill, New York, pp 448–452

    Google Scholar 

  17. 1988 Joint National Committee (1988) The 1988 report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 148:1023–1038

    Article  Google Scholar 

  18. American Diabetes Association (2002) Standards of medical care for patients with diabetes mellitus. Diabetes Care 25(1):213–229

    Google Scholar 

  19. Abbott RD, Brand FN, Kannel WB et al (1988) Gout and coronary heart disease: the Framingham study. J Clin Epidemiol 41(3):237–242

    Article  PubMed  CAS  Google Scholar 

  20. Sudbo J, Lee JJ, Lippman SM et al (2005) Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. Lancet 366(9494):1359–1366

    Article  PubMed  CAS  Google Scholar 

  21. Kanellis J, Watanabe S, Li JH et al (2002) The evidence for a functional organic anion transporter in vascular smooth muscle cells. In: American Society of Nephrology 35th Annual Meeting and Scientific Exposition, Philadelphia, Pa, 30 Oct–4 Nov 2002, 13:329A

  22. Johnson RJ, Kang D-H, Feig D et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190

    Article  PubMed  CAS  Google Scholar 

  23. Ginsberg MH, Kozin F, O’Malley M et al (1977) Release of platelet constituents by monosodium urate crystals. J Clin Invest 60:999–1007

    PubMed  CAS  Google Scholar 

  24. Ginsberg M, Henson P, Henson J et al (1979) Mechanisms of platelet response to monosodium urate crystals. Am J Pathol 94(3):549–568

    PubMed  CAS  Google Scholar 

  25. Boogaerts MA, Hammerschmidt ED, Roelant C et al (1983) Mechanisms of vascular damage in gout and oxalosis: crystal induced, granulocyte mediated, endothelial injury. Thromb Haemost 50(2):576–580

    PubMed  CAS  Google Scholar 

  26. Palella TD, Fox IH (1989) Hyperuricemia and gout. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, p 965

    Google Scholar 

  27. Ridker PM, Genest J, Libby P (2001) Risk factors for atherosclerotic disease. In: Braunwald E, Zipes DP, Libby P (eds) Heart disease: a textbook of cardiovascular medicine, 6th edn. Saunders, Philadelphia, PA, pp 1010–1039

    Google Scholar 

  28. Gelber AC, Klag MJ, Mead LA et al (1997) Gout and risk for subsequent coronary heart disease: the Meharry–Hopkins study. Arch Intern Med 157:1436–1440

    Article  PubMed  CAS  Google Scholar 

  29. Lally EV, Ho G Jr, Kaplan SR (1986) The clinical spectrum of gouty arthritis in women. Arch Intern Med 146:2221–2225

    Article  PubMed  CAS  Google Scholar 

  30. Puig JG, Michan AD, Jimenez ML et al (1991) Female gout: clinical spectrum and uric acid metabolism. Arch Intern Med 151:726–732

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

The authors would like to thank the cardiologist Dr. Lian-Chi Huang who has interpreted the ECG results for this database for nearly 20 years. We have to declare that there are no competing interests for this manuscript.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Heping Branch, Taipei City Hospital, 33, Sec. 2, Junghua Rd., Taipei, Taiwan, Republic of China

    Shih-Yang Chen & Ching-Lang Chen

  2. Division of Biometry, Department of Agronomy, National Taiwan University, Taiwan, Republic of China

    Ming-Lai Shen

Authors
  1. Shih-Yang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ching-Lang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ming-Lai Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shih-Yang Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, SY., Chen, CL. & Shen, ML. Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study. Clin Rheumatol 26, 308–313 (2007). https://doi.org/10.1007/s10067-006-0292-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0292-4

Keywords

Search

Navigation